Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer

INTRODUCTION: D-CARE, an international, phase 3, randomized, double-blind, placebo-controlled study in women with early-stage breast cancer at high risk of disease recurrence, failed to meet its primary endpoint—improvement in bone metastasis-free survival (BMFS) with adjuvant denosumab vs placebo i...

Descripción completa

Detalles Bibliográficos
Autores principales: Coleman, Robert, Zhou, Ying, Jandial, Danielle, Cadieux, Benoit, Chan, Arlene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342342/
https://www.ncbi.nlm.nih.gov/pubmed/34185259
http://dx.doi.org/10.1007/s12325-021-01812-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342342/
https://www.ncbi.nlm.nih.gov/pubmed/34185259
http://dx.doi.org/10.1007/s12325-021-01812-9

Ejemplares similares